Arthropod-Borne Animal Diseases Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: COUNTERMEASURES TO PREVENT, MITIGATE, AND CONTROL RIFT VALLEY FEVER (RVF)

Location: Arthropod-Borne Animal Diseases Research

Title: Design of a shear-thinning recoverable peptide hydrogel from native sequences and application for influenza H1N1 vaccine adjuvant

Authors
item Huang, Hongzhou -
item Shi, Jishu -
item Laskin, Julia -
item Liu, Ziyan -
item McVey, D Scott
item Sun, Xiuzhi -

Submitted to: Soft Matters
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: June 25, 2011
Publication Date: July 21, 2011
Repository URL: http://pubs.rsc.org/en/content/articlepdf/2011/sm/c1sm05157a
Citation: Huang, H., Shi, J., Laskin, J., Liu, Z., Mcvey, D.S., Sun, X.S. 2011. Design of a shear-thinning recoverable peptide hydrogel from native sequences and application for influenza H1N1 vaccine adjuvant. Soft Matters.

Interpretive Summary: A self-assembling peptide was designed and synthesized by rationally combining two native sequences from an elastic segment of spider silk and a trans-membrane segment of human muscle L-type calcium channel. The peptide forms two distinct hydrogels in Ca2+ solution and acidic pH conditions. The shear-thinning, rapid-strength-recovering Ca2+ hydrogel has great potential for drug delivery and tissue engineering applications, for example, as an H1N1 influenza vaccine adjuvant.

Technical Abstract: Peptide hydrogels are considered injectable materials for drug delivery and tissue engineering applications. Most published hydrogel-forming sequences contain either alternating-charged and noncharged residues or amphiphilic blocks. Here, we report a self-assembling peptide, h9e (FLIVIGSIIGPGGDGPGGD), designed by rationally combining two native sequences from an elastic segment of spider silk and a trans-membrane segment of human muscle L-type calcium channel. The turning segment GSII of h9e promoted hydrogel formation in both Ca2+ solution and acidic pH conditions at water content greater than 99.5%. Although h9e Ca2+ hydrogel and h9e acidic hydrogel have the same sequence, they have distinct physical properties. The shear-thinning, rapid-strength-recovering h9e Ca2+ hydrogel was used as an H1N1 influenza vaccine adjuvant. The h9e adjuvant was biologically safe and improved immune response by _70% compared with an oil-based commercial adjuvant.

   

 
Project Team
Wilson, William
Cohnstaedt, Lee
McVey, D Scott - Scott
Nayduch, Dana
Ruder, Mark
Pfannenstiel, Robert - Bob
Drolet, Barbara
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
  Veterinary, Medical and Urban Entomology (104)
 
Related Projects
   RIFT VALLEY FEVER DIAGNOSIS AND VACCINE DEVELOPMENT AND EVALUATION
   IMMUNOLOGICAL CONTROL OF RIFT VALLEY FEVER VIRUS (RVFV) IN AFRICAN RUMINANTS
   RIFT VALLEY FEVER DIAGNOSIS AND VACCINE DEVELOPMENT AND EVALUATION
   EVALUATION OF RIFT VALLEY FEVER DIAGNOSTIC TESTS FOR USE IN A DIVA CONTROL STRATEGY
   DEVELOPMENT OF BIOSENSORS FOR THE DETECTION OF ARBOVIRUSES
   RIFT VALLEY FEVER – DIAGNOSTIC TESTS FOR DIVA CONTROL STRATEGY
   GENERATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR THE RECOMBINANT GN, N AND NSS PROTEINS OF RIFT VALLEY FEVER VIRUS
   RIFT VALLEY FEVER – EXPERIMENTAL VACCINE FORMULATIONS – ADJUVANTS FOR STABILE MODIFIED-LIVE VACCINES AND SUBUNIT VACCINES
   EVALUATION OF RIFT VALLEY FEVER DIAGNOSTIC TESTS FOR USE IN A DIVA CONTROL STRATEGY
 
 
Last Modified: 06/20/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House